Cancer Registration: Principles and Methods - IARC

More documents

Recommendations

Info

Table .- 2. - Average - annual age-specific incidence rates, crude rates (all ages), age-standardized rates (ASR) and cumulative rates in Denmark 1983-87 by primary site and age. Males. I _.. ICD 9th + Revision Site Age-groups (year.) Age un- Crude ASR + 0- 4 5- 9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85-89 90, known Rate worlda' 64b' 74" 0\ 140 Lip 141 'Tongue 142 Salivary gland 143-5 Houth 146 Orophmrynx 147 Naaopharynx 148 Hypopharynx 149 Pharynx unspec. 150 Oesophagu6 151 Stomach 152 Small intestine 153 Colon . 0.2 0.0 0.3 0.4 1.3 1.9 4.4 4.9 11.3 22.4 44.6 69.0 121.9 173.5 245.5 306.7 335.7 314.5 154 Rectum . 0.1 0.1 0.2 1.2 2.0 5.6 11.3 26.9 44.2 68.1 103.7 138.5 176.0 198.2 252.1 263.3 155 Liver 0.4 0.2 0.1 0.1 . 0.0 0.3 0.6 1.3 2.5 4.7 11.2 14.2 25.1 33.0 40.0 31.8 60.5 47.5 156 Gallbladder etc. . 0.0 . 0.1 0.1 0.3 0.7 0.8 1.1 4.8 6.3 10.5 19.1 20.6 22.2 28.3 29.3 157 Pancreas . 0.3 0.7 1.2 2.2 6.3 14.0 20.3 35.4 54.9 78.0 92.2 126.7 119.6 113.4 158 Peritoneum 0.7 . 0.2 0.3 0.7 0.5 0.5 0.5 0.7 1.3 1.2 1.2 2.7 2.7 4.1 5.3 6.2 6.4 11.0 160 Nose. sinuses etc. . 0.0 0.1 0.1 . 0.1 0.3 0.5 0.6 0.9 2.1 1.9 3.8 5.6 4.8 5.6 8.0 9.0 11.0 161 Larynx . 0.2 0.3 1.4 2.3 5.6 11.9 19.1 31.9 32.9 33.3 33.5 26.1 16.7 18.3 162 Bronchus. lung . . 0.1 0.6 0.4 0.7 4.3 11.9 33.9 87.7 166.1 292.8 391.8 489.1 553.1 498.7 382.0 223.1 0 89.0 57.0 2.99 7.40 163 Pleura . 0.1 0.0 0.6 1.0 1.2 2.6 3.3 6.8 6.4 9.6 10.9 11.4 9.0 11.0 0 2.0 1.3 0.08 0.16 164 Other thoracic organs 0.1 . 0.1 0.3 0.3 0.5 0.2 0.1 0.2 0.7 0.9 1.1 1.3 2.2 3.5 0.6 1.7 1.3 0 0.6 0.5 0.03 0.06 170 Bone 0.0 0.4 1.0 1.3 0.7 0.7 0.5 0.7 0.4 0.9 1.2 1.4 2.4 0.9 2.6 0.6 3.4 3.9 7.3 0 1.0 0.8 0.06 0.08 171 Connective tissue 0.1 0.4 0.5 1.1 1.0 1.0 0.8 1.0 1.3 0.5 0.8 2.0 3.2 4.0 6.1 5.0 9.7 10.3 32.9 0 1.7 1.3 0.07 0.12 Helanoma of skin
- 0 - 0 - m o m m L O N I O I O O o o m o L O O . . . . . . . . . . N O 0 0 0 4 0 0 0 0 Reporting of results 117 . . . . . . . . . . N - ~ N o m o m o ' ~ O N O o m P m m ' IO N m r - N - I . - m . " , . . m. o . . m . d. m . 4 I:' m m m O N " , m N IO m N . . . . . . . u , m y m m m m . . 0 - r n d 0 ,004 I-" I- d ? m . . A * r - o . . . . I- LO N N O m o 4 d . m L O - C L O I O N . . . . . I- 0 0 0 L O - N N P I O l . ? ? . - ? : - 0 - m " 0 0 O-, N m m N - , o . m m ? " l " ? O N N . . 0 0 0 0 0 0 0 1 N r( - 4 - - 4 - . . d d d m o
Page 2 and 3:
WORLD HEALTH ORGANIZATION INTERNATI
Page 4 and 5:
Contents Foreword .................
Page 6 and 7:
Foreword The maintenance of a regis
Page 8 and 9:
2 Introduction and an increased exp
Page 10 and 11:
4 G. Wagner the first time to elimi
Page 12 and 13:
6 G. Wagner International Symposium
Page 14 and 15:
8 0. M. Jensen and H.H. Storm made
Page 16 and 17:
k d Table 2. Worldwide variation in
Page 18 and 19:
O.M. Jensen and H.H. Storm Hodgkin
Page 20 and 21:
O.M. Jensen and H.H. Storm ~i~ure 2
Page 22 and 23:
16 O.M. Jensen and H.H. Storm 1oo.0
Page 24 and 25:
0. M. Jensen and H. H. Storm Figure
Page 26 and 27:
O.M. Jensen and H.H. Storm -44 year
Page 28 and 29:
Chapter 4. Planning a cancer regist
Page 30 and 31:
24 0. M. Jensen and S. Whelan parti
Page 32 and 33:
26 0. M. Jensen and S. Whelan Numbe
Page 34 and 35:
28 0. M. Jensen and S. Whelan Concl
Page 36 and 37:
30 J. Powell sources, firstly, to p
Page 38 and 39:
32 J. Powell reports. If a histolog
Page 40 and 41:
34 J. Powell needs but conserving t
Page 42 and 43:
36 J. Powell Health insurance (work
Page 44 and 45:
38 J. Powell episodes-that is, with
Page 46 and 47:
The disadvantages are : - the quali
Page 48 and 49:
42 J. Powell (c) medical doctors in
Page 50 and 51:
44 R. MacLennan Table 1. Basic info
Page 52 and 53:
codes (population groups, occupatio
Page 54 and 55:
48 R. MacLennan morphology (item 21
Page 56 and 57:
50 R. MacLennan or convention to th
Page 58 and 59:
facilities and to the acceptance of
Page 60 and 61:
54 R . MacLennan second generation
Page 62 and 63:
56 R. MacLennan Item 18 : Certainty
Page 64 and 65:
2. Carcinoma in situ Intraepithelia
Page 66 and 67:
code allocated as item 20 should re
Page 68 and 69:
Hospital registries will wish to el
Page 70 and 71:
Chapter 7. Classification and codin
Page 72 and 73: 66 C.S. Muir and C. Percy Primarily
Page 74 and 75: 68 C.S. Muir and C. Percy obtained
Page 76 and 77: 70 C.S. Muir and C. Percy Topograph
Page 78: Table 2. Coding of selected cancers
Page 81 and 82: CIassification and coding of neopla
Page 83 and 84: CIassiJication and coding of neopla
Page 85 and 86: ClassiJication and coding of neopla
Page 87 and 88: Class$cation and coding of neoplasm
Page 89 and 90: Manual and computerized cancer regi
Page 91 and 92: New notification I Manual and compu
Page 99 and 100: Disk storage Manual and computerize
Page 107 and 108: Chapter 9. Quality and quality cont
Page 109 and 110: Quality and quality control 103 It
Page 111 and 112: Consistency checks Quality and qual
Page 113 and 114: Standards Quality and quality contr
Page 115 and 116: 0. M. Jensen and H. H. Storm 109 th
Page 117 and 118: Reporting of results 111 Evaluation
Page 119 and 120: Reporting of results 113 should giv
Page 121: 171 Connective tiaaue 1 3 5 11 10 1
Page 125 and 126: Reporting of results Number of case
Page 127 and 128: Reporting of results Figure 5. Age-
Page 129 and 130: Reporting of results Dlgestlve orga
Page 131 and 132: Reporting of results Year of diagno
Page 133 and 134: Statistical methods for registries
Page 165 and 166: Chapter 12. Analysis of survival D.
Page 167 and 168: Passive follow-up Analysis of survi
Page 169 and 170: Analysis of survival Table 1 - cont
Page 171 and 172: Table 2. Calculation of observed su
Page 173 and 174:
Table 3. Calculation of the correct
Page 175 and 176:
Analysis of survival 169 Table 4. C
Page 177 and 178:
Analysis of survival 171 In the cal
Page 179 and 180:
Analysis of survival 1 73 Table 6.
Page 181 and 182:
Analysis of survival Deaths : cases
Page 183 and 184:
Chapter 13. The hospital-based canc
Page 185 and 186:
The hospital-based cancer registry
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Chapter 14. Cancer registration in
Page 193 and 194:
Cancer registration in developing c
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Chapter 15. Cancer registration: le
Page 207 and 208:
Cancer registration: legal aspects
Page 209 and 210:
Computer Cancer registration : lega
Page 211 and 212:
Cancer registration: legal aspects
Page 213 and 214:
Cancer registration : legal aspects
Page 215 and 216:
Appendix I Botswana Brazil British
Page 217 and 218:
Appendix 1 Sri Lanka Sudan Suriname
Page 219 and 220:
Appendix 2 213 Some of these edits
Page 221 and 222:
Appendix 2 Table 1 - continued (Not
Page 223 and 224:
Table 2. Example of a SEER site/his
Page 225 and 226:
- Appendix 2 219 Follow-up status (
Page 227 and 228:
Appendix 3(a) 221 (c) statistics on
Page 229 and 230:
Appendix 3(a) 223 presence of tumou
Page 231 and 232:
Appendix 3(a) the hospital record.
Page 233 and 234:
Appendix 3(a) 227 REVERSE SIDE OF N
Page 235 and 236:
Appendix 3(a) REVERSE SIDE OF NOTIF
Page 237 and 238:
Data from CPR, i.e. vital Warning o
Page 239 and 240:
Appendix 3(a) 233 place of residenc
Page 241 and 242:
Appendix 3(a) 235 maintained for ta
Page 243 and 244:
Appendix 3 (b) The Thames Cancer Re
Page 245 and 246:
SURGERY Appendix 3(b) TREATMENT OF
Page 247 and 248:
Appendix 3(b) 241 supervised by the
Page 249 and 250:
Appendix 3(b) 243 first for direct
Page 251 and 252:
Appendix 3(b) 245 maintaining an ef
Page 253 and 254:
Appendix 3(c) 247 information on ca
Page 255 and 256:
Appendix 3(c) 249 Pathology reports
Page 257 and 258:
Appendix 3(c) HOSPITAL DISCHARGES L
Page 259 and 260:
Appendix 3(c) Table 1. Groupings of
Page 261 and 262:
Appendix 3(c) 255 several sources a
Page 263 and 264:
Appendix 3(c) 257 resulted in a can
Page 265 and 266:
Appendix 3(d) medical records (in-p
Page 267 and 268:
Appendix 3(d) MOST VALID BASIS OF D
Page 269 and 270:
Appendix 3(d) 263 -malignancies usu
Page 271 and 272:
Appendix 3(d) abstract. For recorde
Page 273 and 274:
Appendix 4. CANREG: Cancer registra
Page 275 and 276:
Appendix 4 Table 1. CANREG internal
Page 277 and 278:
Appendix 4 271 0 Page 1 Patient Nam
Page 279 and 280:
Appendix 4 273 -an operating system
Page 281 and 282:
References Acheson, E. D. (1967) Me
Page 283 and 284:
References 277 oncology services. T
Page 285 and 286:
References International Agency for
Page 287 and 288:
References 281 Official Statistics
Page 289 and 290:
References 283 Sieveking, G. H. (19
Page 291 and 292:
Subject Index Access to data, 202,
Page 293 and 294:
Subject Index International Classif
show all

Cancer Registration: Principles and Methods - IARC

Create successful ePaper yourself

Delete template?

Save as template?